Cytokinetics (CYTK) PT Raised to $48 at JMP Securities
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $77.90 -1.64%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Join SI Premium – FREE
JMP Securities analyst Jason Butler raised the price target on Cytokinetics (NASDAQ: CYTK) to $48.00 (from $44.00) while maintaining a Market Outperform rating on the expanding Ji Xing cardiovascular partnership.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ooma (OOMA) PT Raised to $24 at Freedom Broker
- Yihai International Holding Ltd. (1579:HK) (YNNHF) PT Raised to HK$21.50 at Goldman Sachs
- Yuanta Financial Holding Co Ltd (2885:TT) PT Raised to NT$51.50 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
